Salvage Hemostasis With a Self-Assembling Peptide (Purastat) in Bleeding Duodenal Tumors: A Four-Case Series from Oman Cancer Center
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S679-S680
DOI: 10.1055/s-0046-1821962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von R Matar und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Purastat,is a novel transparent absorbent localized hemostatic agent [ 1 ]. It is self-assembling peptide hydrogel, has been increasingly recognized as a helpful tool in controlling non-variceal gastrointestinal bleeding [ 2 ], particularly in postprocedural oozing and bleeding from small blood vessels in the gastrointestinal tract [ 3 ]. Many studies have documented its effectiveness in spontaneous acute gastrointestinal bleeding [ 4 ] [ 5 ] [ 6 ], post-sphincterotomy bleeding, post-papillectomy bleeding [ 3 ]. However, evidence supporting its role in malignant upper GI bleeding remains scarce. Bleeding due to primary or metastatic gastrointestinal (GI) tumors remains clinically challenging. GI-related tumor bleeding accounts for 12-15% of cases of acute GI hemorrhage [ 7 ] Herein, we report a case series of endoscopic hemostasis using PuraStat as a rescue therapy for bleeding duodenal tumors when standard endoscopic techniques were unsuccessful.
Methods
We reviewed four patients who presented with active bleeding from duodenal malignant tumors. In all cases, standard endoscopic techniques including thermal coagulation or mechanical clipping along with epinephrine injection either failed to control the bleeding or were not feasible because of the friable tumor surface. Purastat was then applied as a salvage therapy. The main outcomes evaluated were immediate hemostasis, early rebleeding within 7 days, the need for additional interventions, changes in transfusion requirements, and any procedure-related complications.
Results
Diffuse oozing and extremely friable tumor surfaces were present in all lesions, significantly reducing the efficacy of standard endoscopic modalities including epinephrine injection, thermal coagulation, and mechanical techniques. When application of Purastat, immediate hemostasis was achieved without any procedure-related complications. Transfusion requirements decreased after treatment, none of the patients experienced early rebleeding as well as the needed for radiologic or surgical intervention.
Conclusions
Our experience indicates that Purastat may be a useful salvage option for Gastrointestinal tumors bleeding, including duodenal tumor bleeding when conventional techniques fails. Purastat was easy to apply, safe, and consistently effective at achieving hemostasis in this small series. These preliminary results support the need for larger prospective studies for Purastat potential role in malignant upper gastrointestinal bleeding Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Matar, R., Sanyour, J., & Qarshoubi, I. A. (2026). Salvage Hemostasis With a Self-Assembling Peptide (Purastat) in Bleeding Duodenal Tumors: A Four-Case Series from Oman Cancer Center. Endoscopy, 58(S 03 S 03), S679-S680. https://doi.org/10.1055/s-0046-1821962
Vancouver
Matar R, Sanyour J, Qarshoubi IA. Salvage Hemostasis With a Self-Assembling Peptide (Purastat) in Bleeding Duodenal Tumors: A Four-Case Series from Oman Cancer Center. Endoscopy. 2026;58(S 03 S 03):S679-S680. doi:10.1055/s-0046-1821962
BibTeX
@article{Matar2026,
author = {Matar, R and Sanyour, J and Qarshoubi, I Al},
title = {Salvage Hemostasis With a Self-Assembling Peptide (Purastat) in Bleeding Duodenal Tumors: A Four-Case Series from Oman Cancer Center},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S679--S680},
doi = {10.1055/s-0046-1821962}
}
EUVIMED